Post-transplantation dynamics of the immune response to chronic myelogenous leukemia

Journal of Theoretical Biology

Volumn 236, Issue 1, 2005, Pages 39-59

  DeConde, Rob ^a   Kim, Peter S ^b   Levy, Doron ^b   Lee, Peter P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Chronic myelogenous leukemia; Delayed differential equations; Immune response; Stem cell transplant

Indexed keywords

IMMUNE RESPONSE; MEDICINE;

ARTICLE; CELL POPULATION; CHRONIC MYELOID LEUKEMIA; GRAFT VERSUS LEUKEMIA EFFECT; IMMUNE RESPONSE; LEUKEMIA CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; POSTOPERATIVE CARE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TUMOR IMMUNITY;

COMPUTER SIMULATION; GRAFT VS HOST REACTION; GRAFT VS LEUKEMIA EFFECT; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MODELS, IMMUNOLOGICAL; RECURRENCE; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; T-LYMPHOCYTES;

EID: 20444440998     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtbi.2005.02.015     Document Type: Article

References (59)

1. E.P. Alyea, R.J. Soiffer, C. Canning, D. Neuberg, R. Schlossman, C. Pickett, H. Collins, Y. Wang, K.C. Anderson, and J. Ritz Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant Blood 19 10 1998 3671 3680
2. R. Antia, C.T. Bergstrom, S.S. Pilyugin, S.M. Kaech, and R. Ahmed Models of CD8+ responses: 1. What is the antigen-independent proliferation program J. Theor. Biol. 221 4 2003 585 598
3. T.P. Arstila, A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky A direct estimate of the human alphabeta T cell receptor diversity Science 286 5441 1999 958 961
4. A. Bagg Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring J. Mol. Diagn. 4 1 2002 1 10
5. S. Bernard, J. Belair, and M.C. Mackey Oscillations in cyclical neutropenia: new evidence based on mathematical modeling J. Theor. Biol. 223 3 2003 283 298
6. J.D. Campbell, G. Cook, and T.L. Holyoake Evolution of bone marrow transplantation - the original immunotherapy Trends Immunol. 22 2 2001 88 92
7. F. Cervantes, J.E. Robertson, C. Rozman, M. Baccarani, S. Tura, G.A. Gomez, T.J. Braun, B.D. Clarkson, and A. Pereira Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study. Group, Italian Cooperative CML Study Group Br. J. Haematol. 87 1994 293 300
8. R. Champlin, I. Khouri, A. Shimoni, J. Gajewski, S. Kornblau, J. Molldrem, N. Ueno, S. Giralt, and P. Anderlini Harnessing graft-versus- malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy Br. J. Haematol. 111 1 2000 18 29
9. Chao, D.L., Forrest, S., Davenport, M.P., Perelson, A.S., 2003. Stochastic stage-structured modeling of the adaptive immune system. Proceedings of the Computational Systems Bioinformatics.
10. R. Childs, D. Epperson, E. Bahceci, E. Clave, and J. Barrett Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect Br. J. Haematol. 107 2 1999 396 400
11. B. Clarkson, and A. Strife Linkage of proliferative and maturational abnormalities in chronic myelogenous leukemia and relevance to treatment Leukemia 7 11 1993 1683 1721
12. R.H. Collins Jr., O. Shpilberg, W.R. Drobyski, D.L. Porter, S. Giralt, R. Champlin, S.A. Goodman, S.N. Wolff, W. Hu, C. Verfaillie, A. List, W. Dalton, N. Ognoskie, A. Chetrit, J.H. Antin, and J. Nemunaitis Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation J. Clin. Oncol. 15 2 1997 433 444
13. W.R. Drobyski, R.C. Ash, J.T. Casper, T. McAuliffe, M.M. Horowitz, C. Lawton, C. Keever, L.A. Baxter-Lowe, B. Camitta, and F. Garbecht Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia Blood 83 1994 1980 1987
14. B.J. Druker, and N.B. Lydon Lessons learned from the development of an ABL tyrosine kinase inhibitor for chronic myelogenous leukemia J. Clin. Invest. 105 1 2000 3 7
15. B.J. Druker, C.L. Sawyers, H. Kantarjian, D.J. Resta, S.F. Reese, J.M. Ford, R. Capdeville, and M. Talpaz Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome N. Engl. J. Med. 344 14 2001 1038 1042
16. F. Dumont-Girard, E. Roux, R.A. van Lier, G. Hale, C. Helg, B. Chapuis, M. Starobinski, and E. Roosnek Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants Blood 92 11 1998 4464 4471
17. C.P. Duvall, and S. Perry The use of 51-chromium in the study of leukocyte kinetics in chronic myelocytic leukemia J. Lab. Clin. Med. 71 1968 614 628
18. P. Essunger, and A.S. Perelson Modeling HIV infection of CD4+ T-cell subpopulations J. Theor. Biol. 170 1994 367 391
19. J.H. Falkenburg, A.R. Wafelman, P. Joosten, W.M. Smit, C.A. van Bergen, R. Bongaerts, E. Lurvink, M. van der Hoorn, P. Kluck, J.E. Landegent, H.C. Kluin-Nelemans, W.E. Fibbe, and R. Willemze Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes Blood 94 4 1999 1201 1208
20. A.S. Fokas, J.B. Keller, and B.D. Clarkson Mathematical model of granulocytopoiesis and chronic myelogenous leukemia Cancer Res. 51 1991 2084 2091
21. P. Friedl, and M. Gunzer Interaction of T cells with APCs: the serial encounter model Trends Immunol. 22 2 2001 187 191
22. B.C. Godthelp, M.J. van Tol, J.M. Vossen, and P.J. van Den Elsen T-cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires Blood 94 1999 4358 4369
23. M.E. Gorre, M. Mohammed, K. Ellwood, N. Hsu, R. Paquette, P.N. Rao, and C.L. Sawyers Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification Science 293 5531 2001 876 880
24. E. Goulmy, R. Schipper, J. Pool, E. Blokland, J.H. Falkenburg, J. Vossen, A. Gratwohl, G.B. Vogelsang, H.C. van Houwelingen, and J.J. van Rood Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation N. Engl. J. Med. 334 5 1996 281 285
25. M.M. Horowitz, R.P. Gale, P.M. Sondel, J.M. Goldman, J. Kersey, H.J. Kolb, A.A. Rimm, O. Ringden, C. Rozman, B. Speck, R.L. Truitt, F.E. Zwaan, and M.M. Bortin Grafte-versus-leukemia reaction after bone marrow transplantation Blood 75 1990 555 562
26. D. Kirschner, and G.F. Webb A model for treatment strategy in the chemotherapy of AIDS Bull. Math. Biol. 58 2 1996 367 390
27. T. Klingebiel, and P.G. Schlegel GVHD: overview on pathophysiology, incidence, clinical and biological features Bone Marrow Transplant 21 Suppl. 2 1998 S45 S49
28. H.J. Kolb, A. Schattenberg, J.M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, and D. Niederwieser Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients, European group for blood and marrow transplantation working party chronic leukemia Blood 86 5 1995 2041 2050
29. K.-A. Kreuzer, C.A. Schmidt, J. Schetelig, T.K. Held, C. Thiede, G. Ehninger, and W. Siegert Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia Eur. J. Haematol. 69 2002 7 10
30. Lee, P.P., Unpublished data.
31. T. Luzyanina, K. Engelborghs, S. Ehl, P. Klenerman, and G. Bocharov Low level viral persistence after infection with LCMV: a quantitative insight through numerical bifurcation analysis Math. Biosci. 173 2004 1 23
32. W.A.E. Marijt, M.H.M. Heemskerk, F.M. Kloosterboer, E. Goulmy, M.G.D. Kester, M.A.W.G. van der Hoorn, S.A.P. van Luxemburg-Heys, M. Hoogeboom, T. Mutis, J.W. Drijfhout, J.J. van Rood, R. Willemze, and J.H.F. Falkenburg Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia Proc. Natl Acad. Sci. 100 5 2003 2742 2747
33. J.J. Molldrem, P.P. Lee, C. Wang, K. Felio, H.M. Kantarjian, R.E. Champlin, and M.M. Davis Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia Nat. Med. 6 8 2000 1018 1023
34. H. Moore, and N.K. Li A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction J. Theor. Biol. 227 2004 513 523
35. K. Murali-Krishna, J.D. Altman, M. Suresh, D.J.D. Sourdive, D.J.D. Zajac, J.D. Miller, J. Slansky, and R. Ahmed Counting antigen-specific CD8+ T cells: a re-evaluation of bystander activation during viral infection Immunity 8 1998 177 187
36. T. Mutis, G. Gillespie, E. Schrama, J.H. Falkenburg, P. Moss, and E. Goulmy Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease Nat. Med. 5 1999 839 842
37. Neiman, B., 2002. A Mathematical Model of Chronic Myelogenous Leukemia. M.Sc. Dissertation, University College, Oxford University, UK.
38. P.W. Nelson, and A.S. Perelson Mathematical analysis of delay differential equation models of HIV-1 infection Math. Biosci. 179 2002 73 94
39. M.A. Nowak, and R.M. May Virus Dynamics 2000 Oxford University Press Oxford, UK
40. P. Paschka, M.C. Muller, K. Merx, S. Kreil, C. Schoch, T. Lahaye, A. Weisser, A. Petzold, H. Konig, U. Berger, H. Gschaidmeier, R. Hehlmann, and A. Hochhaus Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alphs. Low levels of residual disease are associated with continuous remission Leukemia 17 9 2003 1687 1694
41. A.S. Perelson, and P.W. Nelson Mathematical analysis of HIV-I dynamics in vivo SIAM Rev. 41 1 1999 3 44
42. A.S. Perelson, and G. Weisbuch Immunology for physicists Rev. Mod. Phys. 69 4 1997 1219 1267
43. E. Roux, F. Dumont-Girard, M. Starobinski, C.-A. Siegrist, C. Helg, B. Chapuis, and E. Roosnek Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity Blood 96 6 2000 2299 2303
44. C.L. Sawyers, A. Hochhaus, E. Feldman, J.M. Goldman, C.B. Miller, O.G. Ottmann, C.A. Schiffer, M. Talpaz, F. Guilhot, M.W. Deininger, T. Fischer, S.G. O'Brien, R.M. Stone, C.B. Gambacorti-Passerini, N.H. Russell, J.J. Reiffers, T.C. Shea, B. Chapuis, S. Coutre, S. Tura, E. Morra, R.A. Larson, A. Saven, C. Peschel, A. Gratwohl, F. Mandelli, M. Ben-Am, I. Gathmann, R. Capdeville, R.L. Paquette, and B.J. Druker Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study Blood 99 10 2002 3530 3539
45. C.A. Schiffer, R. Hehlmann, and R. Larson Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL Leukemia 17 2003 691 699
46. L.H. Sehn, E.P. Alyea, E. Weller, C. Canning, S. Lee, J. Ritz, J.H. Antin, and R.J. Soiffer Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion J. Clin. Oncol. 17 1999 561 568
47. N.P. Shah, J.M. Nicoll, B. Nagar, M.E. Gorre, R.L. Paquette, J. Kuriyan, and C.L. Sawyers Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia Cancer Cell 2 2 2002 117
48. D.J. Shedlock, and H. Shen Requirement for CD4 T cell help in generating functional CD8 T cell memory Science 300 2003 337 339
49. D.L. Stoler, N. Chen, M. Basik, M.S. Kahlenberg, M.A. Rodriguez-Bigas, N.J. Petrelli, and G.R. Anderson The onset and extent of genomic instability in sporadic colorectal tumor progression Proc. Natl Acad. Sci. USA 96 26 1999 15121 15126
50. J. Storek, M.A. Dawson, B. Storer, T. Stevens-Ayers, M.G. Maloney, K.A. Marr, R.P. Witherspoon, W. Bensinger, M.E.D. Flowers, P. Martin, R. Storb, F.R. Appelbaum, and M. Boeckh Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation Blood 97 11 2001 3380 3389
51. A. Strife, C. Lambek, D. Wisniewski, M. Wachter, S.C. Gulati, and B.D. Clarkson Discordant maturation as the primary biological defect in chronic myelogenous leukemia Cancer Res. 48 4 1988 1035 1041
52. P.A. Stryckmans, L. Debusscher, and E. Collard Cell kinetics in chronic granuclotyci leukaemia (CGL) Clin. Haematol. 6 1 1977 21 40
53. J.C. Sun, and M.J. Beven Defective CD8 T cell memory following acute infection without CD4 T cell help Science 300 2003 339 342
54. T. Tauchi, and K. Ohyashiki Imatinib mesylate in combination with other chemotherapeutic agents for chronic myelogenous leukemia Int. J. Hematol. 79 5 2004 434 440
55. S.F.T. Thijsen, G.J. Schuurhuis, J.W. van Oostveen, and G.J. Ossenkoppele Chronic mlyeloid leukemia from basics to bedside Leukemia 13 1999 1646 1674
56. M. Uzunel, J. Mattsson, M. Brune, J.-E. Johansson, J. Aschan, and O. Ringden Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation Blood 101 2 2003 469 472
57. D. Valmori, V. Dutoit, D. Lienard, F. Lejeune, D. Speiser, D. Rimoldi, V. Cerundolo, P.Y. Dietrich, J.C. Cerottini, and P. Romero Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients J. Immunol. 165 1 2000 533 538
58. M. Villasana, and A. Radunskaya A delay differential equation model for tumor growth J. Math. Biol. 47 2003 270 294
59. E. Zorn, K.S. Wang, E.P. Hochberg, C. Canning, E.P. Alyea, R.J. Soiffer, and J. Ritz Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells Clin. Cancer Res. 8 2002 2052 2060